Toxicologic Pathology of the Peripheral Nervous System (PNS): Overview, Challenges, and Current Practices Article Swipe
Ingrid D. Pardo
,
Deepa B. Rao
,
Mark T. Butt
,
Bernard S. Jortner
,
William M. Valentine
,
Joseph C. Arezzo
,
Alok Sharma
,
Brad Bolon
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1177/0192623318800707
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1177/0192623318800707
Peripheral nervous system (PNS) toxicity is a frequent adverse effect encountered in patients treated with certain therapeutics (e.g., antiretroviral drugs, cancer chemotherapeutics), in occupational workers exposed to industrial chemicals (e.g., solvents), or during accidental exposures to household chemicals and/or environmental agents (e.g., pesticides). However, the literature and expertise needed for the effective design, conduct, analysis, and reporting of safety studies to identify and define PNS toxicity are hard to find. This half-day course familiarized participants with basic PNS biology; causes and mechanisms of PNS pathology; classic methods and current best practice recommendations for PNS sampling, preparation, and evaluation; and examples of commonly observed lesions and artifacts. Three concluding case presentations synthesized information from the prior technical lectures by presenting real-world examples of lesions caused by drugs and chemicals to demonstrate how PNS toxicity may be addressed in evaluating product safety during nonclinical studies. Topics emphasized comparative and correlative data among animal species used in toxicity studies and clinical evaluation in humans in order to facilitate the translation of animal data into human risk assessment with respect to PNS toxicologic pathology.
Related Topics
Concepts
Metadata
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1177/0192623318800707
- https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707
- OA Status
- bronze
- Cited By
- 16
- References
- 38
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2896495569
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2896495569Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1177/0192623318800707Digital Object Identifier
- Title
-
Toxicologic Pathology of the Peripheral Nervous System (PNS): Overview, Challenges, and Current PracticesWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-10-07Full publication date if available
- Authors
-
Ingrid D. Pardo, Deepa B. Rao, Mark T. Butt, Bernard S. Jortner, William M. Valentine, Joseph C. Arezzo, Alok Sharma, Brad BolonList of authors in order
- Landing page
-
https://doi.org/10.1177/0192623318800707Publisher landing page
- PDF URL
-
https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707Direct OA link when available
- Concepts
-
Toxicity, Medicine, Pathology, Peripheral nervous system, Toxicology, Central nervous system, Biology, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
16Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1, 2024: 1, 2023: 1, 2022: 5, 2021: 1Per-year citation counts (last 5 years)
- References (count)
-
38Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2896495569 |
|---|---|
| doi | https://doi.org/10.1177/0192623318800707 |
| ids.doi | https://doi.org/10.1177/0192623318800707 |
| ids.mag | 2896495569 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/30295173 |
| ids.openalex | https://openalex.org/W2896495569 |
| fwci | 0.97182687 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000818 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Animals |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D020258 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Neurotoxicity Syndromes |
| mesh[3].qualifier_ui | Q000139 |
| mesh[3].descriptor_ui | D010523 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | chemically induced |
| mesh[3].descriptor_name | Peripheral Nervous System Diseases |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D000818 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Animals |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D006801 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Humans |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D020258 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Neurotoxicity Syndromes |
| mesh[7].qualifier_ui | Q000139 |
| mesh[7].descriptor_ui | D010523 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | chemically induced |
| mesh[7].descriptor_name | Peripheral Nervous System Diseases |
| type | review |
| title | Toxicologic Pathology of the Peripheral Nervous System (PNS): Overview, Challenges, and Current Practices |
| biblio.issue | 8 |
| biblio.volume | 46 |
| biblio.last_page | 1036 |
| biblio.first_page | 1028 |
| topics[0].id | https://openalex.org/T14072 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9994999766349792 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Immunotoxicology and immune responses |
| topics[1].id | https://openalex.org/T12281 |
| topics[1].field.id | https://openalex.org/fields/34 |
| topics[1].field.display_name | Veterinary |
| topics[1].score | 0.9972000122070312 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3404 |
| topics[1].subfield.display_name | Small Animals |
| topics[1].display_name | Animal testing and alternatives |
| topics[2].id | https://openalex.org/T10433 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9222000241279602 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1306 |
| topics[2].subfield.display_name | Cancer Research |
| topics[2].display_name | Carcinogens and Genotoxicity Assessment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C29730261 |
| concepts[0].level | 2 |
| concepts[0].score | 0.6177186965942383 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q274160 |
| concepts[0].display_name | Toxicity |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5550869107246399 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C142724271 |
| concepts[2].level | 1 |
| concepts[2].score | 0.45485591888427734 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[2].display_name | Pathology |
| concepts[3].id | https://openalex.org/C545314008 |
| concepts[3].level | 3 |
| concepts[3].score | 0.44148018956184387 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q169953 |
| concepts[3].display_name | Peripheral nervous system |
| concepts[4].id | https://openalex.org/C33070731 |
| concepts[4].level | 1 |
| concepts[4].score | 0.37246155738830566 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7218 |
| concepts[4].display_name | Toxicology |
| concepts[5].id | https://openalex.org/C529278444 |
| concepts[5].level | 2 |
| concepts[5].score | 0.2603457570075989 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q47273 |
| concepts[5].display_name | Central nervous system |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.1722308099269867 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.11215198040008545 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/toxicity |
| keywords[0].score | 0.6177186965942383 |
| keywords[0].display_name | Toxicity |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.5550869107246399 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/pathology |
| keywords[2].score | 0.45485591888427734 |
| keywords[2].display_name | Pathology |
| keywords[3].id | https://openalex.org/keywords/peripheral-nervous-system |
| keywords[3].score | 0.44148018956184387 |
| keywords[3].display_name | Peripheral nervous system |
| keywords[4].id | https://openalex.org/keywords/toxicology |
| keywords[4].score | 0.37246155738830566 |
| keywords[4].display_name | Toxicology |
| keywords[5].id | https://openalex.org/keywords/central-nervous-system |
| keywords[5].score | 0.2603457570075989 |
| keywords[5].display_name | Central nervous system |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.1722308099269867 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.11215198040008545 |
| keywords[7].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1177/0192623318800707 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S145558524 |
| locations[0].source.issn | 0192-6233, 1533-1601 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0192-6233 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Toxicologic Pathology |
| locations[0].source.host_organization | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_name | SAGE Publishing |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320017 |
| locations[0].source.host_organization_lineage_names | SAGE Publishing |
| locations[0].license | |
| locations[0].pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Toxicologic Pathology |
| locations[0].landing_page_url | https://doi.org/10.1177/0192623318800707 |
| locations[1].id | pmid:30295173 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Toxicologic pathology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/30295173 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5001203583 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-3517-3804 |
| authorships[0].author.display_name | Ingrid D. Pardo |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I180857899 |
| authorships[0].affiliations[0].raw_affiliation_string | Pfizer, Groton, Connecticut, USA |
| authorships[0].institutions[0].id | https://openalex.org/I180857899 |
| authorships[0].institutions[0].ror | https://ror.org/01xdqrp08 |
| authorships[0].institutions[0].type | company |
| authorships[0].institutions[0].lineage | https://openalex.org/I180857899 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Pfizer (United States) |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ingrid D. Pardo |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Pfizer, Groton, Connecticut, USA |
| authorships[1].author.id | https://openalex.org/A5062347292 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-8149-6401 |
| authorships[1].author.display_name | Deepa B. Rao |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1320320070, https://openalex.org/I1333606569 |
| authorships[1].affiliations[0].raw_affiliation_string | Current employer: Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA |
| authorships[1].institutions[0].id | https://openalex.org/I1333606569 |
| authorships[1].institutions[0].ror | https://ror.org/00yf3tm42 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070, https://openalex.org/I1333606569 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Center for Drug Evaluation and Research |
| authorships[1].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[1].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | United States Food and Drug Administration |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Deepa B. Rao |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Current employer: Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA |
| authorships[2].author.id | https://openalex.org/A5070412458 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-8613-199X |
| authorships[2].author.display_name | Mark T. Butt |
| authorships[2].affiliations[0].raw_affiliation_string | Tox Path Specialists, LLC, Frederick, Maryland, USA |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Mark T. Butt |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Tox Path Specialists, LLC, Frederick, Maryland, USA |
| authorships[3].author.id | https://openalex.org/A5032100986 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-3998-9018 |
| authorships[3].author.display_name | Bernard S. Jortner |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I39822340, https://openalex.org/I859038795 |
| authorships[3].affiliations[0].raw_affiliation_string | Virginia–Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA |
| authorships[3].institutions[0].id | https://openalex.org/I859038795 |
| authorships[3].institutions[0].ror | https://ror.org/02smfhw86 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I859038795 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Virginia Tech |
| authorships[3].institutions[1].id | https://openalex.org/I39822340 |
| authorships[3].institutions[1].ror | https://ror.org/010prmy50 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I39822340, https://openalex.org/I66946132, https://openalex.org/I859038795 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | Virginia–Maryland College of Veterinary Medicine |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Bernard S. Jortner |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Virginia–Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA |
| authorships[4].author.id | https://openalex.org/A5044621021 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9433-353X |
| authorships[4].author.display_name | William M. Valentine |
| authorships[4].affiliations[0].raw_affiliation_string | Cedar Bay Veterinary Clinic, Winter Garden, Florida, USA |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | William M. Valentine |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Cedar Bay Veterinary Clinic, Winter Garden, Florida, USA |
| authorships[5].author.id | https://openalex.org/A5073909635 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8216-6490 |
| authorships[5].author.display_name | Joseph C. Arezzo |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I129975664 |
| authorships[5].affiliations[0].raw_affiliation_string | Albert Einstein College of Medicine, Bronx, New York, USA |
| authorships[5].institutions[0].id | https://openalex.org/I129975664 |
| authorships[5].institutions[0].ror | https://ror.org/05cf8a891 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I129975664, https://openalex.org/I4210112371 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Albert Einstein College of Medicine |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Joseph Arezzo |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Albert Einstein College of Medicine, Bronx, New York, USA |
| authorships[6].author.id | https://openalex.org/A5007855596 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-7014-4753 |
| authorships[6].author.display_name | Alok Sharma |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I60638368 |
| authorships[6].affiliations[0].raw_affiliation_string | Covance Laboratories Inc., Madison, Wisconsin, USA |
| authorships[6].institutions[0].id | https://openalex.org/I60638368 |
| authorships[6].institutions[0].ror | https://ror.org/02hhsqf45 |
| authorships[6].institutions[0].type | company |
| authorships[6].institutions[0].lineage | https://openalex.org/I60638368 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Covance (United States) |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Alok K. Sharma |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Covance Laboratories Inc., Madison, Wisconsin, USA |
| authorships[7].author.id | https://openalex.org/A5011929463 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-6065-1492 |
| authorships[7].author.display_name | Brad Bolon |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210103264 |
| authorships[7].affiliations[0].raw_affiliation_string | GEMpath Inc., Longmont, Colorado, USA *Ingrid D. Pardo and Deepa B. Rao contributed equally to production of this article. |
| authorships[7].institutions[0].id | https://openalex.org/I4210103264 |
| authorships[7].institutions[0].ror | https://ror.org/01d7a8h40 |
| authorships[7].institutions[0].type | other |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210103264 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | NewPath Research |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Brad Bolon |
| authorships[7].is_corresponding | True |
| authorships[7].raw_affiliation_strings | GEMpath Inc., Longmont, Colorado, USA *Ingrid D. Pardo and Deepa B. Rao contributed equally to production of this article. |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Toxicologic Pathology of the Peripheral Nervous System (PNS): Overview, Challenges, and Current Practices |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T14072 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9994999766349792 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Immunotoxicology and immune responses |
| related_works | https://openalex.org/W2748952813, https://openalex.org/W3031052312, https://openalex.org/W4389568370, https://openalex.org/W3032375762, https://openalex.org/W1995515455, https://openalex.org/W2080531066, https://openalex.org/W2586801360, https://openalex.org/W3108674512, https://openalex.org/W1506200166, https://openalex.org/W1489783725 |
| cited_by_count | 16 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 1 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 1 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 5 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 1 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 2 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 5 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1177/0192623318800707 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S145558524 |
| best_oa_location.source.issn | 0192-6233, 1533-1601 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0192-6233 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Toxicologic Pathology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_name | SAGE Publishing |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| best_oa_location.source.host_organization_lineage_names | SAGE Publishing |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Toxicologic Pathology |
| best_oa_location.landing_page_url | https://doi.org/10.1177/0192623318800707 |
| primary_location.id | doi:10.1177/0192623318800707 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S145558524 |
| primary_location.source.issn | 0192-6233, 1533-1601 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0192-6233 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Toxicologic Pathology |
| primary_location.source.host_organization | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_name | SAGE Publishing |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320017 |
| primary_location.source.host_organization_lineage_names | SAGE Publishing |
| primary_location.license | |
| primary_location.pdf_url | https://journals.sagepub.com/doi/pdf/10.1177/0192623318800707 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Toxicologic Pathology |
| primary_location.landing_page_url | https://doi.org/10.1177/0192623318800707 |
| publication_date | 2018-10-07 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W2745994394, https://openalex.org/W2125151252, https://openalex.org/W2064776597, https://openalex.org/W2803868380, https://openalex.org/W2119847157, https://openalex.org/W1937717046, https://openalex.org/W1484789769, https://openalex.org/W2141410612, https://openalex.org/W2026709638, https://openalex.org/W1980204643, https://openalex.org/W2065172953, https://openalex.org/W2592468357, https://openalex.org/W2000836320, https://openalex.org/W2071396842, https://openalex.org/W2288779047, https://openalex.org/W2110244140, https://openalex.org/W2397014632, https://openalex.org/W1984677607, https://openalex.org/W4238318416, https://openalex.org/W280568877, https://openalex.org/W3022626577, https://openalex.org/W2028615324, https://openalex.org/W2088366744, https://openalex.org/W2152603172, https://openalex.org/W2176373479, https://openalex.org/W2163354698, https://openalex.org/W2159862960, https://openalex.org/W2037977626, https://openalex.org/W2040057801, https://openalex.org/W2286535726, https://openalex.org/W2147300396, https://openalex.org/W344575546, https://openalex.org/W2091260221, https://openalex.org/W1533916889, https://openalex.org/W2733793054, https://openalex.org/W2802901464, https://openalex.org/W2026261759, https://openalex.org/W2067583385 |
| referenced_works_count | 38 |
| abstract_inverted_index.a | 6 |
| abstract_inverted_index.be | 134 |
| abstract_inverted_index.by | 117, 124 |
| abstract_inverted_index.in | 11, 22, 136, 153, 159, 161 |
| abstract_inverted_index.is | 5 |
| abstract_inverted_index.of | 57, 82, 100, 121, 167 |
| abstract_inverted_index.or | 31 |
| abstract_inverted_index.to | 26, 35, 60, 68, 128, 163, 176 |
| abstract_inverted_index.PNS | 64, 77, 83, 93, 131, 177 |
| abstract_inverted_index.and | 46, 55, 62, 80, 87, 96, 98, 104, 126, 146, 156 |
| abstract_inverted_index.are | 66 |
| abstract_inverted_index.for | 49, 92 |
| abstract_inverted_index.how | 130 |
| abstract_inverted_index.may | 133 |
| abstract_inverted_index.the | 44, 50, 113, 165 |
| abstract_inverted_index.This | 70 |
| abstract_inverted_index.best | 89 |
| abstract_inverted_index.case | 108 |
| abstract_inverted_index.data | 148, 169 |
| abstract_inverted_index.from | 112 |
| abstract_inverted_index.hard | 67 |
| abstract_inverted_index.into | 170 |
| abstract_inverted_index.risk | 172 |
| abstract_inverted_index.used | 152 |
| abstract_inverted_index.with | 14, 75, 174 |
| abstract_inverted_index.(PNS) | 3 |
| abstract_inverted_index.Three | 106 |
| abstract_inverted_index.among | 149 |
| abstract_inverted_index.basic | 76 |
| abstract_inverted_index.drugs | 125 |
| abstract_inverted_index.find. | 69 |
| abstract_inverted_index.human | 171 |
| abstract_inverted_index.order | 162 |
| abstract_inverted_index.prior | 114 |
| abstract_inverted_index.(e.g., | 17, 29, 41 |
| abstract_inverted_index.Topics | 143 |
| abstract_inverted_index.agents | 40 |
| abstract_inverted_index.and/or | 38 |
| abstract_inverted_index.animal | 150, 168 |
| abstract_inverted_index.cancer | 20 |
| abstract_inverted_index.caused | 123 |
| abstract_inverted_index.causes | 79 |
| abstract_inverted_index.course | 72 |
| abstract_inverted_index.define | 63 |
| abstract_inverted_index.drugs, | 19 |
| abstract_inverted_index.during | 32, 140 |
| abstract_inverted_index.effect | 9 |
| abstract_inverted_index.humans | 160 |
| abstract_inverted_index.needed | 48 |
| abstract_inverted_index.safety | 58, 139 |
| abstract_inverted_index.system | 2 |
| abstract_inverted_index.adverse | 8 |
| abstract_inverted_index.certain | 15 |
| abstract_inverted_index.classic | 85 |
| abstract_inverted_index.current | 88 |
| abstract_inverted_index.design, | 52 |
| abstract_inverted_index.exposed | 25 |
| abstract_inverted_index.lesions | 103, 122 |
| abstract_inverted_index.methods | 86 |
| abstract_inverted_index.nervous | 1 |
| abstract_inverted_index.product | 138 |
| abstract_inverted_index.respect | 175 |
| abstract_inverted_index.species | 151 |
| abstract_inverted_index.studies | 59, 155 |
| abstract_inverted_index.treated | 13 |
| abstract_inverted_index.workers | 24 |
| abstract_inverted_index.However, | 43 |
| abstract_inverted_index.biology; | 78 |
| abstract_inverted_index.clinical | 157 |
| abstract_inverted_index.commonly | 101 |
| abstract_inverted_index.conduct, | 53 |
| abstract_inverted_index.examples | 99, 120 |
| abstract_inverted_index.frequent | 7 |
| abstract_inverted_index.half-day | 71 |
| abstract_inverted_index.identify | 61 |
| abstract_inverted_index.lectures | 116 |
| abstract_inverted_index.observed | 102 |
| abstract_inverted_index.patients | 12 |
| abstract_inverted_index.practice | 90 |
| abstract_inverted_index.studies. | 142 |
| abstract_inverted_index.toxicity | 4, 65, 132, 154 |
| abstract_inverted_index.addressed | 135 |
| abstract_inverted_index.analysis, | 54 |
| abstract_inverted_index.chemicals | 28, 37, 127 |
| abstract_inverted_index.effective | 51 |
| abstract_inverted_index.expertise | 47 |
| abstract_inverted_index.exposures | 34 |
| abstract_inverted_index.household | 36 |
| abstract_inverted_index.reporting | 56 |
| abstract_inverted_index.sampling, | 94 |
| abstract_inverted_index.technical | 115 |
| abstract_inverted_index.Peripheral | 0 |
| abstract_inverted_index.accidental | 33 |
| abstract_inverted_index.artifacts. | 105 |
| abstract_inverted_index.assessment | 173 |
| abstract_inverted_index.concluding | 107 |
| abstract_inverted_index.emphasized | 144 |
| abstract_inverted_index.evaluating | 137 |
| abstract_inverted_index.evaluation | 158 |
| abstract_inverted_index.facilitate | 164 |
| abstract_inverted_index.industrial | 27 |
| abstract_inverted_index.literature | 45 |
| abstract_inverted_index.mechanisms | 81 |
| abstract_inverted_index.pathology. | 179 |
| abstract_inverted_index.pathology; | 84 |
| abstract_inverted_index.presenting | 118 |
| abstract_inverted_index.real-world | 119 |
| abstract_inverted_index.solvents), | 30 |
| abstract_inverted_index.comparative | 145 |
| abstract_inverted_index.correlative | 147 |
| abstract_inverted_index.demonstrate | 129 |
| abstract_inverted_index.encountered | 10 |
| abstract_inverted_index.evaluation; | 97 |
| abstract_inverted_index.information | 111 |
| abstract_inverted_index.nonclinical | 141 |
| abstract_inverted_index.synthesized | 110 |
| abstract_inverted_index.toxicologic | 178 |
| abstract_inverted_index.translation | 166 |
| abstract_inverted_index.familiarized | 73 |
| abstract_inverted_index.occupational | 23 |
| abstract_inverted_index.participants | 74 |
| abstract_inverted_index.pesticides). | 42 |
| abstract_inverted_index.preparation, | 95 |
| abstract_inverted_index.therapeutics | 16 |
| abstract_inverted_index.environmental | 39 |
| abstract_inverted_index.presentations | 109 |
| abstract_inverted_index.antiretroviral | 18 |
| abstract_inverted_index.recommendations | 91 |
| abstract_inverted_index.chemotherapeutics), | 21 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5011929463 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| corresponding_institution_ids | https://openalex.org/I4210103264 |
| citation_normalized_percentile.value | 0.70369979 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |